Publications by authors named "Eric Beys"

Claim this Profile
P
Preclinical Activity of SAR408701: A Novel Anti-CEACAM5-maytansinoid Antibody-drug Conjugate for the Treatment of CEACAM5-positive Epithelial Tumors.
Stéphanie Decary, Pierre-François Berne, Céline Nicolazzi, Anne-Marie Lefebvre, Tarik Dabdoubi, Eric Beys

Clin Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical profile of cabazitaxel.
Patricia Vrignaud, Dorothée Semiond, Veronique Benning, Eric Beys, Hervé Bouchard

Drug Des Devel Ther· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis